HPSE and Anxiety: Interestingly, recent studies showed that hemopressin, an inverse agonist of the CB1 receptor, induced anxiogenic-like effects (Fogaça et al., 2015); thus, we hypothesized that the new peptidic endocannabinoid (m)VD-HPα might counteract the anxiety-like behavior and sleep disturbances.